- Home
- EHTH vs LUNG Comparison
EHTH vs LUNG Comparison
Compare EHTH & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- LUNG
- Stock Information
- Founded
- EHTH 1997
- LUNG 1995
- Country
- EHTH United States
- LUNG United States
- Employees
- EHTH N/A
- LUNG N/A
- Industry
- EHTH Specialty Insurers
- LUNG Industrial Specialties
- Sector
- EHTH Finance
- LUNG Health Care
- Exchange
- EHTH Nasdaq
- LUNG Nasdaq
- Market Cap
- EHTH 289.2M
- LUNG 256.3M
- IPO Year
- EHTH 2006
- LUNG 2020
- Fundamental
- Price
- EHTH $10.05
- LUNG $6.26
- Analyst Decision
- EHTH Hold
- LUNG Buy
- Analyst Count
- EHTH 5
- LUNG 6
- Target Price
- EHTH $7.70
- LUNG $11.92
- AVG Volume (30 Days)
- EHTH 377.8K
- LUNG 236.5K
- Earning Date
- EHTH 02-25-2025
- LUNG 02-19-2025
- Dividend Yield
- EHTH N/A
- LUNG N/A
- EPS Growth
- EHTH N/A
- LUNG N/A
- EPS
- EHTH N/A
- LUNG N/A
- Revenue
- EHTH $464,891,000.00
- LUNG $79,302,000.00
- Revenue This Year
- EHTH $11.84
- LUNG $22.26
- Revenue Next Year
- EHTH $5.69
- LUNG $18.72
- P/E Ratio
- EHTH N/A
- LUNG N/A
- Revenue Growth
- EHTH 15.78
- LUNG 22.34
- 52 Week Low
- EHTH $3.58
- LUNG $5.46
- 52 Week High
- EHTH $10.68
- LUNG $14.84
- Technical
- Relative Strength Index (RSI)
- EHTH 69.37
- LUNG 44.05
- Support Level
- EHTH $8.51
- LUNG $6.24
- Resistance Level
- EHTH $10.68
- LUNG $7.27
- Average True Range (ATR)
- EHTH 0.64
- LUNG 0.39
- MACD
- EHTH -0.06
- LUNG -0.02
- Stochastic Oscillator
- EHTH 75.29
- LUNG 5.61
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.